Metastasis inhibitor composition comprising a phospholipid-linke

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 25, 514 42, 514 56, 514 62, 536 172, 536 179, 536 182, 536 187, 536 21, 536 53, 536 55, 536 551, 536 552, 5361231, A61K 31715, C08B 3700, C07H 100

Patent

active

057338922

ABSTRACT:
This invention relates to compounds prepared by linking glycosaminoglycan to phospholipid or lipid, which are expected to exert a pharmacological effect for inhibiting metastasis because of their excellent function to inhibit adhesion of cancer cells to blood vessel endothelial cells and extracellular matrix. This phospholipid- or lipid-linked glycosaminoglycan can be produced for example by: cleaving and oxidizing reducing terminal group of glycosaminoglycan, and allowing an aldehyde group or a lactone compound of the thus-formed derivative or a carboxyl group in the glycosaminoglycan chain to react with a primary amino group of a phospholipid; or linking a glycosaminoglycan derivative to a phospholipid or a lipid by allowing a primary amino group of the derivative to react with a carboxyl group of the phospholipid or lipid. This phospholipid- or lipid-linked glycosaminoglycan is useful as a metastasis inhibitor because it has no toxicity.

REFERENCES:
patent: 4239754 (1980-12-01), Sache et al.
patent: 4362737 (1982-12-01), Schafer et al.
patent: 4604376 (1986-08-01), Teng
patent: 4654327 (1987-03-01), Teng
patent: 4882318 (1989-11-01), Vlodavsky et al.
patent: 5118671 (1992-06-01), Bombardelli et al.
patent: 5120719 (1992-06-01), Iwamoto et al.
patent: 5169636 (1992-12-01), Nanba et al.
patent: 5292509 (1994-03-01), Hageman
Tsubura et al, "Cancer Invasion and Metastasis", Biolog. Mech & Ther., pp. 367-381 (1977), month not available.
Vannucchi et al, Biochem. J., 227:57-65 (1985), month not available.
Coombe et al, Int. J. Cancer, 39(1): 82-88 (1987), month not available.
Parish et al, Int. J. Cancer, 40:511-518 (1987), month not available.
Hall et al, Biomaterials, 10(4):219-224 (1989), month not available.
Kim et al, Thromb. Res., 56:369-376 (1989), month not available.
Lee et al, Chemical Abstracts, 113:17566 (1990), month not available.
Soeda et al, Biochemistry, 29:5188-5194 (1990), month not available.
van Boeckel et al. Pure & Appl. Chem. 1995, 67(10), 1663-1672, month not available.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Metastasis inhibitor composition comprising a phospholipid-linke does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Metastasis inhibitor composition comprising a phospholipid-linke, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metastasis inhibitor composition comprising a phospholipid-linke will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-52055

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.